The
World Health Organisation has published a second draft on the “Revision of its
Process Validation Guideline”.
According
to ECA, the table of contents and the scope have remained unchanged. Yet, the
definition of process validation contains the life-cycle approach in the
glossary already. Compared to the first draft, the new version now also
explains the matrix approach or bracketing.
The
main change is with the chapter "process qualification". Here it is
stated that a risk assessment is required for the change in batch size from
scale up to commercial batch size. Explicitly, manufacturers are requested to
implement the new validation approach. However, it is mentioned that full
implementation may take time. In the interim, the traditional approach or
concurrent validation may be accepted. Also a hybrid approach (based on a
scientific basis and risk management principles) may be an alternative.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources